Budgetary Discharge: European Medicines Agency (2021)

by name voted on 10.05.2023

Summary

The European Parliament has approved the 2021 budget implementation for the European Medicines Agency, praising its COVID-19 response while warning about staff shortages and high lease liabilities.

9 10.05.2023

Other

budget

health

equal treatment

public administration

information technology and data processing

Key points

The European Parliament granted discharge and approved the closure of the EMA's accounts for the 2021 financial year.
The agency played a crucial role in the COVID-19 response, assessing vaccines and treatments with unprecedented speed.
There is growing concern that increasing workloads are not being met with enough staff, leading to potential burnout.
The agency needs to take concrete steps to improve gender balance in its senior management levels.

Vote

PPE

S&D

Renew

Verts/ALE

ECR

ID

NI

The Left

Total

Documents (PDFs)

REPORT on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2021 Discharge 2021: European Medicines Agency

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.